189 related articles for article (PubMed ID: 18301769)
1. IdeS: a bacterial proteolytic enzyme with therapeutic potential.
Johansson BP; Shannon O; Björck L
PLoS One; 2008 Feb; 3(2):e1692. PubMed ID: 18301769
[TBL] [Abstract][Full Text] [Related]
2. Anchoring IgG-degrading enzymes to the surface of platelets selectively neutralizes antiplatelet antibodies.
Lynch DR; Stringham EN; Zhang B; Balbin-Cuesta G; Curtis BR; Palumbo JS; Greineder CF; Tourdot BE
Blood Adv; 2022 Aug; 6(15):4645-4656. PubMed ID: 35737875
[TBL] [Abstract][Full Text] [Related]
3. Blocking of experimental arthritis by cleavage of IgG antibodies in vivo.
Nandakumar KS; Johansson BP; Björck L; Holmdahl R
Arthritis Rheum; 2007 Oct; 56(10):3253-60. PubMed ID: 17907170
[TBL] [Abstract][Full Text] [Related]
4. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G.
von Pawel-Rammingen U; Johansson BP; Björck L
EMBO J; 2002 Apr; 21(7):1607-15. PubMed ID: 11927545
[TBL] [Abstract][Full Text] [Related]
5. IdeS, a highly specific immunoglobulin G (IgG)-cleaving enzyme from Streptococcus pyogenes, is inhibited by specific IgG antibodies generated during infection.
Akesson P; Moritz L; Truedsson M; Christensson B; von Pawel-Rammingen U
Infect Immun; 2006 Jan; 74(1):497-503. PubMed ID: 16369006
[TBL] [Abstract][Full Text] [Related]
6. IdeS, a secreted proteinase of Streptococcus pyogenes, is bound to a nuclease at the bacterial surface where it inactivates opsonizing IgG antibodies.
Frick IM; Happonen L; Wrighton S; Nordenfelt P; Björck L
J Biol Chem; 2023 Nov; 299(11):105345. PubMed ID: 37838172
[TBL] [Abstract][Full Text] [Related]
7. Toward Clinical use of the IgG Specific Enzymes IdeS and EndoS against Antibody-Mediated Diseases.
Collin M; Björck L
Methods Mol Biol; 2017; 1535():339-351. PubMed ID: 27914091
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding.
Vincents B; von Pawel-Rammingen U; Björck L; Abrahamson M
Biochemistry; 2004 Dec; 43(49):15540-9. PubMed ID: 15581366
[TBL] [Abstract][Full Text] [Related]
9. Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia.
Kizlik-Masson C; Deveuve Q; Zhou Y; Vayne C; Thibault G; McKenzie SE; Pouplard C; Loyau S; Gruel Y; Rollin J
Blood; 2019 May; 133(22):2427-2435. PubMed ID: 30917957
[TBL] [Abstract][Full Text] [Related]
10. The deficient cleavage of M protein-bound IgG by IdeS: insight into the escape of Streptococcus pyogenes from antibody-mediated immunity.
Su YF; Chuang WJ; Wang SM; Chen WY; Chiang-Ni C; Lin YS; Wu JJ; Liu CC
Mol Immunol; 2011 Oct; 49(1-2):134-42. PubMed ID: 21925735
[TBL] [Abstract][Full Text] [Related]
11. IgG-degrading enzyme of Streptococcus pyogenes (IdeS) prevents disease progression and facilitates improvement in a rabbit model of Guillain-Barré syndrome.
Wang Y; Shi Q; Lv H; Hu M; Wang W; Wang Q; Qiao B; Zhang G; Lv Z; Kjellman C; Järnum S; Winstedt L; Zhang Y; Wen J; Hao Y; Yuki N
Exp Neurol; 2017 May; 291():134-140. PubMed ID: 28214515
[TBL] [Abstract][Full Text] [Related]
12. Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG.
Wenig K; Chatwell L; von Pawel-Rammingen U; Björck L; Huber R; Sondermann P
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17371-6. PubMed ID: 15574492
[TBL] [Abstract][Full Text] [Related]
13. The Bacterial Enzyme IdeS Cleaves the IgG-Type of B Cell Receptor (BCR), Abolishes BCR-Mediated Cell Signaling, and Inhibits Memory B Cell Activation.
Järnum S; Bockermann R; Runström A; Winstedt L; Kjellman C
J Immunol; 2015 Dec; 195(12):5592-601. PubMed ID: 26553074
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel host-specific IgG protease in Streptococcus phocae subsp. phocae.
Rungelrath V; Wohlsein JC; Siebert U; Stott J; Prenger-Berninghoff E; von Pawel-Rammingen U; Valentin-Weigand P; Baums CG; Seele J
Vet Microbiol; 2017 Mar; 201():42-48. PubMed ID: 28284621
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin cleavage by the streptococcal cysteine protease IdeS can be detected using protein G capture and mass spectrometry.
Hess JL; Porsch EA; Shertz CA; Boyle MD
J Microbiol Methods; 2007 Aug; 70(2):284-91. PubMed ID: 17543400
[TBL] [Abstract][Full Text] [Related]
16. IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.
Collin M; Shannon O; Björck L
Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4265-70. PubMed ID: 18332429
[TBL] [Abstract][Full Text] [Related]
17. Complete Removal of Extracellular IgG Antibodies in a Randomized Dose-Escalation Phase I Study with the Bacterial Enzyme IdeS--A Novel Therapeutic Opportunity.
Winstedt L; Järnum S; Nordahl EA; Olsson A; Runström A; Bockermann R; Karlsson C; Malmström J; Palmgren GS; Malmqvist U; Björck L; Kjellman C
PLoS One; 2015; 10(7):e0132011. PubMed ID: 26177518
[TBL] [Abstract][Full Text] [Related]
18. IdeS and SpeB: immunoglobulin-degrading cysteine proteinases of Streptococcus pyogenes.
von Pawel-Rammingen U; Björck L
Curr Opin Microbiol; 2003 Feb; 6(1):50-5. PubMed ID: 12615219
[TBL] [Abstract][Full Text] [Related]
19. Streptococcal IdeS: therapeutic potential for Guillain-Barré syndrome.
Takahashi R; Yuki N
Sci Rep; 2015 Jul; 5():10809. PubMed ID: 26194472
[TBL] [Abstract][Full Text] [Related]
20. IdeS (Imlifidase): A Novel Agent That Cleaves Human IgG and Permits Successful Kidney Transplantation Across High-strength Donor-specific Antibody.
Lonze BE; Tatapudi VS; Weldon EP; Min ES; Ali NM; Deterville CL; Gelb BE; Benstein JA; Dagher NN; Wu M; Montgomery RA
Ann Surg; 2018 Sep; 268(3):488-496. PubMed ID: 30004918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
